BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 692485)

  • 1. [Accidental contamination with protactinium 231 treated with DTPA].
    Giubileo M
    Med Lav; 1978 Jun; 69 Suppl 3():413-25. PubMed ID: 692485
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental model on DTPA therapy of radioactivity contaminated wounds].
    Bömer H
    Strahlentherapie; 1972 Jun; 143(6):664-9. PubMed ID: 5071563
    [No Abstract]   [Full Text] [Related]  

  • 3. Interpretation of human urinary excretion of plutonium for cases treated with DTPA.
    Jech JJ; Andersen BV; Heid KR
    Health Phys; 1972 Jun; 22(6):787-92. PubMed ID: 5084012
    [No Abstract]   [Full Text] [Related]  

  • 4. Urinary excretion of 241Am under DTPA therapy.
    Fasiska BC; Bohning DE; Brodsky A; Horm J
    Health Phys; 1971 Oct; 21(4):523-9. PubMed ID: 5115125
    [No Abstract]   [Full Text] [Related]  

  • 5. Effectiveness of early DTPA treatments in two types of plutonium exposures in humans.
    Lagerquist CR; Hammond SE; Putzier EA; Piltingsrud CW
    Health Phys; 1965 Nov; 11(11):1177-80. PubMed ID: 5867870
    [No Abstract]   [Full Text] [Related]  

  • 6. Biokinetic modelling of DTPA decorporation therapy: the CONRAD approach.
    Breustedt B; Blanchardon E; Berard P; Fritsch P; Giussani A; Lopez MA; Luciani A; Nosske D; Piechowski J; Schimmelpfeng J; Sérandour AL
    Radiat Prot Dosimetry; 2009 Feb; 134(1):38-48. PubMed ID: 19351653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Zn-DTPA and Ca-DTPA in removing plutonium from the human body.
    Ohlenschläger L; Schieferdecker H; Schmidt-Martin W
    Health Phys; 1978 Nov; 35(5):694-9. PubMed ID: 744734
    [No Abstract]   [Full Text] [Related]  

  • 8. [Report on a perforating and incised wound on the left forefinger contaminated with Americium 241].
    Ohlenschläger L
    Strahlentherapie; 1971 Jul; 142(1):73-9. PubMed ID: 5116427
    [No Abstract]   [Full Text] [Related]  

  • 9. Plutonium ( 239 Pu) toxicity diagnosis and therapy.
    Norwood WD
    J Occup Med; 1972 Jan; 14(1):37-44. PubMed ID: 5058618
    [No Abstract]   [Full Text] [Related]  

  • 10. Radiochemical determination of protactinium-231 in environmental and biological materials.
    Sill CW
    Anal Chem; 1978 Sep; 50(11):1559-71. PubMed ID: 707812
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic removal of internally deposited transuranium elements.
    Smith VH
    Health Phys; 1972 Jun; 22(6):765-78. PubMed ID: 5084009
    [No Abstract]   [Full Text] [Related]  

  • 12. Importance of initial management of persons internally contaminated with radionuclides.
    Lincoln TA
    Am Ind Hyg Assoc J; 1976 Jan; 37(1):16-21. PubMed ID: 1246944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of human contamination with plutonium and americium: would orally administered Ca- or Zn-DTPA be effective?
    Taylor DM; Hodgson SA; Stradling N
    Radiat Prot Dosimetry; 2007; 127(1-4):469-71. PubMed ID: 17556346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diethylene-triamine-penta-acetate administration protocol for radiological emergency medicine in nuclear fuel reprocessing plants.
    Jin Y
    Hemoglobin; 2008; 32(1-2):199-206. PubMed ID: 18274997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Modeling of cutaneous radio-contamination: effects of washings by soap and by solutions of DTPA].
    Gerasimo P; Jourdain D; Cazoulat A; Schoulz D; Laroche P; Ducousso R
    Ann Pharm Fr; 1997; 55(3):116-24. PubMed ID: 9239860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Report on a plutonium-239 contaminated lacerated and incised wound].
    Ohlenschläger L; Schieferdecker H
    Strahlentherapie; 1973 Dec; 146(6):675-84. PubMed ID: 4792264
    [No Abstract]   [Full Text] [Related]  

  • 17. MR Gd-DTPA enhancement of radiation brain injury.
    Nishimura R; Takahashi M; Morishita S; Sumi M; Uozumi H; Sakamoto Y
    Radiat Med; 1992; 10(3):109-16. PubMed ID: 1509102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of actinide exposures: a review of Ca-DTPA injections inside CEA-COGEMA plants.
    Grappin L; Berard P; Menetrier F; Carbone L; Courtay C; Castagnet X; Le Goff JP; Neron MO; Piechowski J
    Radiat Prot Dosimetry; 2007; 127(1-4):435-9. PubMed ID: 17940101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decorporation of plutonium by pulmonary administration of Ca-DTPA dry powder: a study in rat after lung contamination with different plutonium forms.
    Sérandour AL; Tsapis N; Gervelas C; Grillon G; Fréchou M; Deverre JR; Bénech H; Fattal E; Fritsch P; Poncy JL
    Radiat Prot Dosimetry; 2007; 127(1-4):472-6. PubMed ID: 17562654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A method for determining 231Pa in biological samples.
    Gies RA; Ballou JE; Case AC; Ryan JL
    Health Phys; 1984 Apr; 46(4):928-32. PubMed ID: 6706601
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.